S028 Late-breaking Research: Session 1
DESCRIPTION
The Late Breaking Abstract sessions invite investigators to submit their most recent unpublished research in all areas of dermatology. Following a competitive review, the highest-rated studies will be selected for brief oral presentations. The session will highlight practice-changing clinical trials, population-based studies, transformative technologies, translational biomarker research, and groundbreaking basic science. Topics covering skin, hair, and nail disorders will be considered, with a focus on findings that advance our understanding of disease mechanisms, therapy development, or adverse event prevention.
LEARNING OBJECTIVES
Discuss the latest research findings can translate into improved patient care, focusing on new treatments, diagnostic tools, and emerging trends in dermatology.
Describe how scientific discoveries and technological advancements in dermatology can be practically integrated into everyday clinical practice, addressing both common and complex dermatologic conditions.
Discuss insights into cutting-edge industry developments, including new pharmaceutical products, devices, and technologies, and how these innovations might shape the future of dermatological treatments.
SCHEDULE
9:00 AM
Advancing Skin Cancer Diagnostics: Novel Insights with Automated Total Body Photography at a Tertiary Care Center
Jordan S. Phillipps, MD
9:12 AM
Deucravacitinib in the Treatment of Lichen Planopilaris: Final 28-Week Analysis
Alyssa Stockard
9:24 AM
Efficacy and Safety of Ruxolitinib Cream in Patients With Prurigo Nodularis: Results From a Phase 3, Randomized, Vehicle-Controlled Study (TRuE-PN1)
Shawn Kwatra, MD, FAAD
9:36 AM
“Super-response” following treatment with delgocitinib cream 20 mg/g in a subgroup of patients with moderate to severe Chronic Hand Eczema
April W. Armstrong, MD, MPH, FAAD
9:48 AM
QY201 in adults with moderate-to-severe atopic dermatitis: 12-week results from a dose-finding phase 2 trial
Jianhui Li
10:00 AM
Tapinarof Cream 1% Once Daily: Maintenance of Low Disease Activity Including Pruritus Through End of the Treatment-free Interval in a Long-term Extension Trial in Patients Down to 2 Years of Age...
David Rosmarin, MD, FAAD
10:12 AM
Cutaneous Immune-Related Adverse Events as Indicators of Subsequent Multiorgan Toxicities in Immune Checkpoint Inhibitor Therapy
Elle Kim
10:24 AM
Three-phase, adaptive clinical trial to evaluate the human factors of a patient-led patch testing protocol for the diagnosis of allergic contact dermatitis
Charles Bruce
10:36 AM
Initial Results From The SIGNAL-AA Study: Randomized Placebo Controlled Phase 2a Trial of a Bempikibart, Novel IL-7/TSLP Bifunctional Receptor Antagonist in Patients with Severe or Very Severe...
Brett King, MD, PhD, FAAD
10:48 AM
A Multi-Centre Clinical Performance Review of an Artificial Intelligence as a Medical Device in Excluding a Diagnosis of Melanoma in Urgent Suspected Skin Cancer Pathways
Dilraj Kalsi
11:00 AM
Efficacy and safety of ESK-001, a highly selective oral TYK2 inhibitor, in moderate-to-severe plaque psoriasis: long term Phase 2 results
Andrew Blauvelt, MD, FAAD
11:12 AM
Dupilumab Reduces Itch in Epidermolysis Bullosa and Congenital Ichthyosis: Interim Analysis from a Single-Site, Investigator-Initiated Pilot Study
Kennedy Gallagher
11:24 AM
Icotrokinra, a Targeted Oral Peptide That Selectively Blocks the Interleukin-23–Receptor, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results Through Week 24 of the Phase 3, Randomized..
Robert Bissonnette, MSc, MD, FAAD
11:36 AM
Efficacy and safety of oral deucravacitinib in patients with cutaneous manifestations of lupus erythematosus: results from PAISLEY CLE, a global, phase 2 randomized, double-blind, placebo-controlled..
Victoria P. Werth, MD, FAAD
11:48 AM
Efficacy and safety of deucravacitinib in patients with active psoriatic arthritis who are naive to biologic disease-modifying anti-rheumatic drugs or previously received TNF inhibitor treatment...
Diamant Thaci
DIRECTOR
Hensin Tsao, MD, PhD, FAAD
CO-DIRECTORS
Murad Alam, MD, FAAD
April W. Armstrong, MD, MPH, FAAD
Kristina Patrice Callis-Duffin, MD, FAAD
Robert Paul Dellavalle, MD, PhD, FAAD
Joel M. Gelfand, MD, MSCE, FAAD
Kenneth B. Gordon, MD, FAAD
Sewon Kang, MD, FAAD
Paul Nghiem, MD, PhD, FAAD
Amy S. Paller, MD, FAAD
Sandy Sharon Tsao, MD, FAAD
SPEAKERS
Robert Bissonnette, MSc, MD, FAAD
Andrew Blauvelt, MD, FAAD
Charles Bruce
Kennedy Gallagher
Dilraj Kalsi
Elle Kim
Brett King, MD, PhD, FAAD
Shawn Kwatra, MD, FAAD
Jianhui Li
Jordan S. Phillipps, MD
David Rosmarin, MD, FAAD
Alyssa Stockard
Diamant Thaci
Victoria P. Werth, MD, FAAD
HANDOUTS
DISCLOSURES
Murad Alam, MD, FAAD
No financial relationships exist with ineligible companies.
April W. Armstrong, MD, MPH, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Consultant(Honoraria); Boehringer Ingelheim – Data Safety Monitoring Board(Honoraria); Bristol-Myers Squibb – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Consultant(Honoraria); Dermsquared – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria); Galderma USA – Advisory Board(Honoraria); Incyte – Consultant (1099 relationship)(Honoraria); Janssen Biotech – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ortho Dermatologics – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);
Robert Bissonnette, MSc, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Aldena Therapeutics – Investigator(Grants/Research Funding); Almirall – Consultant (1099 relationship)(Honoraria); Alumis – Investigator(Grants/Research Funding); Amgen – Consultant(Honoraria), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); Arena Pharmaceuticals – Investigator(Grants/Research Funding); Areteia Therapeutics – Consultant (1099 relationship)(Honoraria); Artax Biopharma – Investigator(Grants/Research Funding); Attovia Therapeutics – Investigator(Grants/Research Funding); BioMimetix JV, LLC – Investigator(Grants/Research Funding); Bluefin Biomedicine – Investigator(Grants/Research Funding); BMS – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Brickell Biotech, Inc – Investigator(Grants/Research Funding); Cara Therapeutics – Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria); Escient Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Horizon Therapeutics Ireland DAC – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Inmagene Biopharmaceuticals – Consultant(Honoraria), Investigator(Grants/Research Funding); Innovaderm Research Inc. – Stockholder(Stock); Janssen Scientific Affairs, LLC – Consultant(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Merck – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Nektar Therapeutics – Investigator(Grants/Research Funding); Nimbus Therapeutics – Investigator(Grants/Research Funding); opsidio – Investigator(Grants/Research Funding); Organon – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Pelage Pharmaceuticals – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Q32 Bio Inc. – Investigator(Grants/Research Funding); RAPT Therapeutics – Consultant(Honoraria); Sanofi Aventis – Consultant(Honoraria); Sanofi Genzyme – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Sitryx – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Takeda Development Center Americas, Inc. – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); TARGET Pharma – Consultant(Honoraria), Investigator(Grants/Research Funding); Triveni Bio – Investigator(Grants/Research Funding); UCB – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Ventyx Biosciences – Investigator(Grants/Research Funding); VYNE Therapeutics – Investigator(Grants/Research Funding); Xencor – Investigator(Grants/Research Funding); Zai Lab – Investigator(Grants/Research Funding); Zura Bio – Investigator(Grants/Research Funding);
Andrew Blauvelt, MD, FAAD
AbbVie – Consultant(Honoraria); Almirall – Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); AnaptysBio – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Speaker(Honoraria); Incyte Corporation – Consultant(Honoraria); Janssen-Ortho Inc. – Consultant(Honoraria); Leo Pharma – Speaker(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Lipidio Pharmaceuticals – Stockholder Private Company(Stock); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria), Stockholder Public Company(Stock); Pfizer Inc. – Consultant(Honoraria); Regeneron – Consultant(Honoraria); Sanofi – Consultant(Honoraria), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria), Speaker(Honoraria);
Charles Bruce
No financial relationships exist with ineligible companies.
Kristina Patrice Callis-Duffin, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria), Stockholder Public Company(No Compensation Received); Alumis – Investigator(Grants/Research Funding); Amgen – Advisory Board(Honoraria), Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Celgene Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding); FIDE – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis – Consultant(Honoraria), Investigator(Grants/Research Funding); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Stockholder Public Company(No Compensation Received);
Robert Paul Dellavalle, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Kennedy Gallagher
No financial relationships exist with ineligible companies.
Joel M. Gelfand, MD, MSCE, FAAD
AbbVie – Consultant(Fees); Amgen – Investigator(Grants/Research Funding); Artax Biopharma – Data Safety Monitoring Board(Fees); BMS – Consultant(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); CellDex – Data Safety Monitoring Board(Fees); Daavlin Company – Other(Equipment); FIDE – Consultant(Fees); Healio – Other(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); International Psoriasis Council – Board of Directors(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Leo Pharma Inc – Consultant(Fees); Maui Derm – Speaker/Faculty Education(Fees); Medical Dermatology Society – Board of Directors(No Compensation Received); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neuroderm LTD – Other(Fees); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Other(Fees); Veolia North America – Consultant(Fees);
Kenneth B. Gordon, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
Dilraj Kalsi
Skin Analytics – Employee – Lab does sell products(Stock Options);
Sewon Kang, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria); CeraVe/Valeante – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria); Estee Lauder – Advisory Board(Honoraria); Galderma USA – Advisory Board(Honoraria); Incyte Corporation – Data Safety Monitoring Board(Fees); Rapalogix Health – Advisory Board(Stock Options); Walgreens Boots Alliance, Inc. – Investigator(Grants/Research Funding);
Elle Kim
No financial relationships exist with ineligible companies.
Brett King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Aquestive Therapeutics – Consultant (1099 relationship)(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Galderma – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Leo Pharma – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Sanofi Genzyme – Speaker(Honoraria); Soterios Pharma – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant(Fees), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Shawn Kwatra, MD, FAAD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); Castle Biosciences, Inc – Consultant(Honoraria); Galderma – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Johnson and Johnson – Advisory Board(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Jianhui Li
No financial relationships exist with ineligible companies.
Paul Nghiem, MD, PhD, FAAD
Almirall – Consultant(Honoraria); Bristol-Myers Squibb – Investigator(Grants/Research Funding); EMD Serono – Consultant(Fees); Merck & Co., Inc – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria);
Amy S. Paller, MD, FAAD
AbbVie – Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding); Abeona Therapeutics – Data Safety Monitoring Board(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); BioMendics, LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Daiichi Sankyo – Data Safety Monitoring Board(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Galderma – Data Safety Monitoring Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Pelthos Therapeutics – Consultant (1099 relationship)(Honoraria); Quoin Pharmaceuticals Ltd – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);
Jordan S. Phillipps, MD
No financial relationships exist with ineligible companies.
David Rosmarin, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Abcuro, Inc. – Consultant(Honoraria); Almirall – Consultant (1099 relationship)(Honoraria); AltruBio Inc. – Consultant(Honoraria); Amgen – Speaker(Honoraria); Arena Pharmaceuticals – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Celgene Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Concert Pharmaceuticals – Consultant(Honoraria), Data Safety Monitoring Board(Honoraria); CSL Behring – Consultant(Honoraria); Dermavant Sciences – Advisory Board(Honoraria), Speaker(Honoraria); Dermira – Consultant(Honoraria); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding), Other(Other Financial Benefit), Speaker(Honoraria); Janssen Biotech – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Merck & Co., Inc – Investigator(Grants/Research Funding); Nektar Therapeutics – Consultant (1099 relationship)(Honoraria); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); RAPT Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Recludix Pharma – Consultant (1099 relationship)(Honoraria); Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Revolo Therapeutics – Consultant(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); UCB – Advisory Board(Honoraria); Viela Bio – Advisory Board(Honoraria); Zura Bio – Consultant (1099 relationship)(Honoraria);
Alyssa Stockard
No financial relationships exist with ineligible companies.
Diamant Thaci
AbbVie – Advisory Board(Honoraria), Investigator(Fees), Speaker/Faculty Education(Honoraria); Almirall – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Amgen – Speaker/Faculty Education(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Fees), Speaker/Faculty Education(Honoraria); Celltrion – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Galderma – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Janssen-Cilag – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees), Speaker(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Investigator(Fees); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Fees), Speaker/Faculty Education(Honoraria); Regeneron – Investigator(Fees), Speaker/Faculty Education(Honoraria); Samsung Bioepis – Consultant(Honoraria); Sanofi – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Target RWE – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria), Investigator(Fees), Speaker/Faculty Education(Honoraria);
Hensin Tsao, MD, PhD, FAAD
Epiphany Dermatology – Advisory Board(Honoraria), Advisory Board(Stock Options); Massachusetts General Hospital – Employee(Salary); UpToDate, Inc. – Other(Honoraria); Worldcare Clinical, LLC – Consultant (1099 relationship)(Fees);
Sandy Sharon Tsao, MD, FAAD
Beiersdorf, Inc. – Consultant (1099 relationship)(Honoraria); Epiphany Dermatology – Advisory Board(Stock); WorldCare Clinical LLC – Consultant (1099 relationship)(Honoraria);
Victoria P. Werth, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); Architect Therapeutics – Consultant (1099 relationship)(Fees); argenx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Astra Zeneca – Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Atticus Pharma, Inc. – Consultant (1099 relationship)(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Celexor Bio – Consultant (1099 relationship)(Fees); Corbus Pharmaceuticals – Investigator(Grants/Research Funding); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); Duality Bio – Consultant (1099 relationship)(Fees); EMD Serono – Consultant(Honoraria); Everest Clinical Research – Consultant (1099 relationship)(Honoraria); Exo Therapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Glycoera – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lumanity – Consultant (1099 relationship)(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Odyssey Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); ROME Therapeutics – Consultant(Honoraria); Sanofi Aventis – Consultant(Honoraria); UCB – Consultant(Honoraria); Ventus Therapeutics – Investigator(Grants/Research Funding); Viela Bio – Consultant(Honoraria), Investigator(Grants/Research Funding); Vindico Medical Education – Speaker/Faculty Education(Honoraria);